What is Sildenafil Citrate, and How Does It Work?
Sildenafil citrate is an inhibitor of...
Revolutionizing Genomic Solutions: NGS Informatics Market to Reach $4.3 Billion
Insights into NGS Informatics Market GrowthMeticulous Research® recently released a report entitled “Next Generation Sequencing (NGS) Informatics Market by Offering (Data Analysis, Interpretation & Reporting, Storage & Computing, LIMS), Application (Diagnostic, Drug Discovery, Precision Medicine, Biomarker Discovery) End User - Global Forecast to 2030.” This report estimates that the NGS informatics market will reach $4.3 billion by 2030, exhibiting a CAGR of 15.4% during the forecast period. Factors propelling this growth include increased research funding from pharmaceutical and biotech companies, a rising incidence of cancer and genetic disorders, enhanced adoption of NGS for diagnostic and precision medicine applications, and ongoing technological innovations in NGS informatics solutions. Additionally, government initiatives promoting large-scale genomic sequencing are contributing positively, although concerns surrounding data security remain a hurdle for market expansion.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3483
The growing use of NGS informatics tools in clinical settings and the expanding role of bioinformatics in genomic data management are expected to present considerable opportunities for market players. Conversely, the lack of qualified professionals to operate NGS informatics tools presents a significant challenge.
Market Segmentation and Future Prospects
The NGS informatics market is categorized by offering, which includes software (data analysis, interpretation, and reporting tools, along with data storage and computing solutions, and LIMS), deployment mode (web/cloud-based and on-premise solutions), and applications (disease diagnoses, biomarker discovery, drug discovery, precision medicine, agriculture, and animal research). It also includes an analysis of end users, such as pharmaceutical and biotechnology companies, hospitals, diagnostic labs, academic and research institutes, and various geographical regions. The report evaluates industry competitors and provides insights into market dynamics at regional and country levels.
By offering, the software segment is projected to hold the largest market share in 2023. This is driven by the software's ability to efficiently process, store, and share extensive NGS and genomic datasets, along with a growing demand for scalable genomic data storage solutions.
When considering applications, drug discovery is anticipated to capture the largest share of the NGS informatics market in 2023. This growth is fueled by decreasing sequencing costs, the ability of NGS to identify numerous mutations tied to genetic disorders, and a rising adoption of sequencing technologies in pharmaceutical and biotechnology research.
Regarding end users, pharmaceutical and biotechnology firms are expected to dominate the NGS informatics market share in 2023, due to their increased focus on R&D, outsourcing of projects to CROs, and a continual reduction in sequencing costs.
Regional Market Analysis
The research report also offers a detailed geographic analysis, focusing on key regions such as North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and other European nations), Asia-Pacific (China, Japan, India, and the wider Asia-Pacific area), Latin America (Brazil, Mexico, and the rest of Latin America), and the Middle East & Africa.
North America is forecasted to maintain the largest market share of the NGS informatics sector in 2023, followed by Europe and Asia-Pacific. The U.S. is expected to be a significant market leader within North America. This market growth is largely attributed to rising R&D expenditures in the pharmaceutical and biotechnology industries, the presence of key players in NGS informatics, supportive government initiatives for genomics research, and a favorable reimbursement landscape for NGS-based tests.
Conclusion
The next generation sequencing informatics market is poised for significant growth, driven by advancements in technology, increased funding in research, and broader adoption of NGS technologies across various applications. While data security concerns and a lack of skilled professionals pose challenges, the overall outlook remains positive, with ample opportunities for market players to innovate and expand their offerings.
Browse in Depth : https://www.meticulousresearch.com/product/ngs-informatics-market-3483
Key Players
The key players operating in the next generation sequencing (NGS) informatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Sapio Sciences, LLC (U.S.), DNASTAR, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), Partek Incorporated (U.S.), and DNAnexus, Inc. (U.S.).
Key questions answered in the report:
- Which are the high-growth market segments in terms of offering, application, end user, and region/country?
- What was the historical market size for next generation sequencing (NGS) informatics across the globe?
- What are the market forecasts and estimates for the period 2023–2030?
- What are the major drivers, restraints, challenges, and opportunities in the global next generation sequencing (NGS) informatics market?
- Who are the major players in the global next generation sequencing (NGS) informatics market?
- How is the competitive landscape, and who are the market leaders in the global next generation sequencing (NGS) informatics market?
- What are the recent developments in the next generation sequencing (NGS) informatics market?
- What are the different strategies adopted by the major players in the next generation sequencing (NGS) informatics market?
- What are the geographical trends and high growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Please login to comment on this Post